• LAST PRICE
    39.2900
  • TODAY'S CHANGE (%)
    Trending Down-0.2000 (-0.5065%)
  • Bid / Lots
    39.2700/ 1
  • Ask / Lots
    39.3100/ 2
  • Open / Previous Close
    39.5300 / 39.4900
  • Day Range
    Low 38.9000
    High 39.8700
  • 52 Week Range
    Low 25.0400
    High 44.4200
  • Volume
    721,812
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 39.49
TimeVolumeIONS
09:32 ET1462839.32
09:34 ET417739.23
09:36 ET120039.53
09:38 ET63039.235
09:39 ET130039.105
09:41 ET80039.01
09:43 ET418939.04
09:45 ET1905739.29
09:48 ET134539.2
09:50 ET121339.3
09:52 ET60039.42
09:54 ET327639.59
09:56 ET325739.565
09:57 ET185739.595
09:59 ET70039.55
10:01 ET272539.4
10:03 ET215039.25
10:06 ET4149839.31
10:08 ET140039.43
10:10 ET50039.355
10:12 ET161239.37
10:14 ET10039.39
10:15 ET275739.52
10:17 ET180039.75
10:19 ET80839.64
10:21 ET68039.55
10:24 ET200039.595
10:26 ET50039.62
10:28 ET90039.5
10:30 ET100039.67
10:32 ET150039.71
10:33 ET72239.755
10:35 ET67439.7502
10:37 ET70039.66
10:39 ET224039.63
10:42 ET50039.535
10:44 ET116539.53
10:46 ET2296539.625
10:48 ET170039.64
10:50 ET50039.78
10:51 ET173339.74
10:53 ET639139.69
10:55 ET83039.69
10:57 ET120039.715
11:00 ET275039.62
11:02 ET40039.72
11:04 ET20039.7
11:06 ET130539.6825
11:08 ET20039.67
11:09 ET30039.61
11:11 ET40039.57
11:13 ET606239.485
11:15 ET357739.42
11:18 ET6256339.4
11:20 ET5898139.215
11:22 ET99939.29
11:24 ET300039.28
11:26 ET90039.46
11:27 ET100039.37
11:29 ET30039.405
11:31 ET145039.4
11:33 ET20039.415
11:36 ET2494939.49
11:38 ET15830739.38
11:40 ET371939.42
11:42 ET30239.425
11:44 ET90739.3776
11:47 ET20039.33
11:49 ET5409339.11
11:51 ET199239.09
11:54 ET40039.16
11:56 ET24139.23
11:58 ET180139.15
12:00 ET20039.065
12:02 ET50039.03
12:03 ET120039.116
12:05 ET45839.1
12:07 ET80039.18
12:09 ET90039.15
12:12 ET241439.12
12:14 ET120039.18
12:16 ET67039.15
12:18 ET126539.13
12:20 ET90339.16
12:21 ET145139.25
12:23 ET143339.35
12:25 ET54039.395
12:27 ET162139.33
12:30 ET86739.33
12:32 ET100039.2
12:34 ET80039.31
12:36 ET20239.3
12:38 ET50039.325
12:39 ET80039.29
12:41 ET70039.255
12:43 ET190039.25
12:45 ET80039.29
12:48 ET80039.26
12:50 ET20039.185
12:52 ET30039.205
12:54 ET260039.17
12:56 ET5200039.31
12:57 ET65839.32
12:59 ET70039.34
01:01 ET40039.29
01:03 ET50039.29
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIONS
Ionis Pharmaceuticals Inc
5.6B
-1,423.0x
---
United StatesSRPT
Sarepta Therapeutics Inc
6.2B
-17.1x
---
United StatesAZTA
Azenta Inc
5.2B
-225.7x
---
United StatesCRSP
CRISPR Therapeutics AG
4.4B
15.2x
---
United StatesHALO
Halozyme Therapeutics Inc
6.1B
14.9x
---
United StatesALKS
Alkermes Plc
4.9B
-77.4x
---
As of 2022-05-23

Company Information

Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on our cardiovascular and neurology franchises. Its products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for the treatment of patients of all ages with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. TEGSEDI is for the treatment of patients with polyneuropathy caused by hereditary transthyretin (TTR), amyloidosis (hATTR), a debilitating, progressive, and fatal disease. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients. The Company has over six medicines in Phase III studies for eight indications, which include Eplontersen (TTR), Olezarsen (ApoC-III), Donidalorsen (PKK), ION363 (FUS), Pelacarsen (Apo(a)) and Tofersen (SOD1). Its cardiovascular medicine in development includes Eplontersen, Olezarsen, Pelacarsen, ION449 (PCSK9), Fesomersen and IONIS-AGT-LRx.

Contact Information

Headquarters
2855 Gazelle CtCARLSBAD, CA, United States 92010-6670
Phone
760-931-9200
Fax
302-655-5049

Executives

Independent Chairman of the Board
Joseph Loscalzo
Chief Executive Officer, Director
Brett Monia
Chief Financial Officer, Executive Vice President - Finance
Elizabeth Hougen
Executive Vice President, Chief Scientific Officer
C. Frank Bennett
Executive Vice President, Chief Business Officer
Joseph Baroldi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.6B
Revenue (TTM)
$840.8M
Shares Outstanding
141.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.71
EPS
$-0.03
Book Value
$5.47
P/E Ratio
-1,423.0x
Price/Sales (TTM)
6.7
Price/Cash Flow (TTM)
406.4x
Operating Margin
-0.52%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.